Company Update: Novozymes first quater

The recently completed acquisition of EMD/Merck Crop BioScience strengthens the company’s capabilities in the domain and has already impacted sales in the microorganism sales area in this first quarter. Sales of microorganisms were up by 95 percent in Danish kroner, mainly due to the contribution from the acquisitions of EMD/Merck Crop BioScience and Turfal completed this year and last year respectively.

Solid first-quarter sales, earnings, and cash flow

Sales, earnings, and cash flow had a solid development in the first quarter. Sales grew by 16 percent in Danish kroner (DKK) and by 14 percent in local currencies (LCY). Acquisitions contributed positively at approximately five percent - points. EBIT grew by a strong 19 percent, taking the EBIT margin to 23.6 percent. Read more ...
 
This blog is written by Martin Little The Global Miller, published and supported by the GFMT Magazine and International Milling Directory from Perendale Publishers